Zebra Medical Vision

Zebra Medical Vision develops an imaging analytics platform that leverages artificial intelligence and deep learning to help healthcare institutions identify patients at risk of disease and offer preventative treatment pathways to improve patient care. The company's AI solutions analyze millions of clinical imaging data points in real time, detecting various medical indications across radiology, cardiology, oncology, and orthopedics. Founded in 2014 by Eyal Gura and Eyal Toledano in Kibbutz Shefayim, Israel, Zebra's high-performance software secured multiple regulatory approvals including FDA and CE clearances, and was installed in hospitals globally. The company was named one of Fast Company's Top-5 AI and Machine Learning companies and raised $52 million across six funding rounds before being acquired by Nanox Vision in August 2021 in a deal valued at up to $200 million.